Update on deep brain stimulation for Parkinson's disease

Journal of Neurosurgical Sciences

Volumn 56, Issue 4, 2012, Pages 267-277

  Terzic, D ^a   Abosch, A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Deep brain stimulation; Neurosurgery; Parkinson disease

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

BRAIN DEPTH STIMULATION; BRAIN ELECTROPHYSIOLOGY; COMPULSION; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTRODE; GASTROINTESTINAL SYMPTOM; GLOBUS PALLIDUS; HALLUCINATION; HUMAN; IMPLANTABLE PULSE GENERATOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATIENT SAFETY; PATIENT SELECTION; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEIZURE; STEREOTACTIC PROCEDURE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

BRAIN; DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 84871746306     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Guridi J, Lozano AM. A brief history of pallidotomy. Neurosurgery 1997;41:1169-80; discussion 1180-1163.
2. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-80. (Pubitemid 13189531)
3. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci U S A 1983;80:4546-50. (Pubitemid 13077876)
4. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-8.
5. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987;50:344-6. (Pubitemid 18043161)
6. Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 1993;58:39-44.
7. Limousin P, Pollak P, Benazzouz A, Hoffman D, Broussolle E, Perret JE et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 1995;10:672-4.
8. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355:896-908. (Pubitemid 44315982)
9. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama 2009;301:63-73.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
11. Visser JE, Allum JHJ, Carpenter MG, Esselink RAJ, Limousin-Dowsey P, Honegger F et al. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease. Neuroscience. 2008;157:798-812.
12. Marsden CD, Parkes JD. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1977;1:345-9. (Pubitemid 8024416)
13. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000;342:1484-91. (Pubitemid 30318272)
14. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, eds. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987. p. 153-64.
15. Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002;59:932-4.
16. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605-14.
17. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003;99:489-95. (Pubitemid 37040409)
18. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123(Pt 10):2091-108.
19. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007;106:621-5. (Pubitemid 46536458)
20. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008;23:343-9.
21. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002;50:1268-74; discussion 1274-1266.
22. Coley E, Farhadi R, Lewis S, Whittle IR. The incidence of seizures following Deep Brain Stimulating electrode implantation for movement disorders, pain and psychiatric conditions. Br J Neurosurg 2009;23:179-83.
23. Okun MS, Tagliati M, Pourfar M, Fernandez HH, Rodriguez RL, Alterman RL et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005;62:1250-5. (Pubitemid 41168352)
24. Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schupbach M et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008;131(Pt 10):2720-8.
25. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004;115:1239-48. (Pubitemid 38596707)
26. Rosin B, Slovik M, Mitelman R, Rivlin-Etzion M, Haber SN, Israel Z et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72:370-84.
27. Burchiel KJ, Anderson VC, Favre J, Hammerstad JP. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-82; discussion 1382-1374.
28. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-60. (Pubitemid 40489885)
29. Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg 2005;103:956-67. (Pubitemid 43194543)
30. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
31. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129(Pt 7):1732-47. (Pubitemid 43999407)
32. Ferraye MU, Debu B, Fraix V, Goetz L, Ardouin C, Yelnik J et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133(Pt 1):205-14.
33. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130(Pt 6):1596-607. (Pubitemid 47355911)
34. Zrinzo L, Hariz M. The peripeduncular nucleus: a novel target for deep brain stimulation? Neuroreport 2007;18:1631-2; author reply 1632-1633.
35. Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 2012;37:213-46.
36. Bronte-Stewart H, Louie S, Batya S, Henderson JM. Clinical motor outcome of bilateral subthalamic nucleus deep-brain stimulation for Parkinson's disease using image-guided frameless stereotaxy. Neurosurgery 2010;67:1088-93; discussion 1093.
37. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain with guide to the atlas for stereotaxy of the human brain. Thieme; Lslf edition; 1977. p. 15.
38. Starr PA. Placement of deep brain stimulators into the subthalamic nucleus or Globus pallidus internus: technical approach. Stereotactic and Functional Neurosurgery 2002;79:118-45. (Pubitemid 36928765)
39. Patel NK, Khan S, Gill SS. Comparison of atlas- and magnetic-resonance- imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson's disease. Stereotax Funct Neurosurg 2008;86:153-61. (Pubitemid 351685462)
40. Ashkan K, Blomstedt P, Zrinzo L, Tisch S, Yousry T, Limousin-Dowsey P et al. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br J Neurosurg 2007;21:197-200. (Pubitemid 46572892)
41. Richter EO, Hoque T, Halliday W, Lozano AM, Saint-Cyr JA. Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurgery 2004;100:541-6. (Pubitemid 38269084)
42. Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 tesla. Neurosurgery 2010;67:1745-56; discussion 1756.
43. Huston OO, Watson RE, Bernstein MA, McGee KP, Stead SM, Gorman DA et al. Intraoperative magnetic resonance imaging findings during deep brain stimulation surgery. J Neurosurgery 2011;115:852-7.
44. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurgery 2010;112:479-90.
45. Bour LJ, Contarino MF, Foncke EMJ, de Bie RMA, van den Munckhof P, Speelman JD et al. Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir (Wien) 2010;152:2069-77.
46. Zrinzo L, Foltynie T, Limousin P, Hariz ML Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurgery 2012;116:84-94.
47. Hutchison WD, Lang AE, Dostrovsky JO, Lozano AM. Pallidal neuronal activity: implications for models of dystonia. Ann Neurol 2003;53:480-8. (Pubitemid 36373259)
48. Harries AM, Kausar J, Roberts SAG, Mocroft AP, Hodson JA, Pall HS et al. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results. J Neurosurgery 2012;116:107-13.
49. Wong S, Baltuch GH, Jaggi JL, Danish SF. Functional localization and visualization of the subthalamic nucleus from microelectrode recordings acquired during DBS surgery with unsupervised machine learning. J Neural Eng 2009;6:026006.
50. Cagnan H, Dolan K, He X, Contarino MF, Schuurman R, can den Munckhof P et al. Automatic subthalamic nucleus detection from microelectrode recordings based on noise level and neuronal activity. J Neural Eng 2011;8:046006.
51. Gupte AA, Shrivastava D, Spaniol MA, Abosch A. MRI-related heating near deep brain stimulation electrodes: more data are needed. Stereotact Funct Neurosurg 2011;89:131-140.
52. Rezai AR, Baker KB, Tkach JA, Phillips M, Hrdlicka G, Sharan AD et al. Is magnetic resonance imaging safe for patients with neurostimulation systems used for deep brain stimulation? Neurosurgery 2005;57:1056-62; discussion 1056-1062.
53. Roark C, Whicher S, Abosch A. Reversible neurological symptoms caused by diathermy in a patient with deep brain stimulators: case report. Neurosurgery 2008;62:E256; discussion E256.
54. Martens HCF, Toader E, Decre MMJ, Anderson DJ, Vetter R, Kipke DR et al. Spatial steering of deep brain stimulation volumes using a novel lead design. Clinical neurophysiology: official journal of the International Federation of Clin Neurophysiol 2011;122:558-66.
55. Butson CR, Maks CB, McIntyre CC. Sources and effects of electrode impedance during deep brain stimulation. Clin Neurophysiol 2006;117:447-54. (Pubitemid 43228036)
56. Histed MH, Bonin V, Reid RC. Direct activation of sparse, distributed populations of cortical neurons by electrical microstimulation. Neuron 2009;63:508-22.
57. Wei XF, Grill WM. Impedance characteristics of deep brain stimulation electrodes in vitro and in vivo. J Neural Eng 2009;6:046008.
58. Rosa M, Marceglia S, Servello D, Foffani G, Rossi L, Sassi M et al. Time dependent subthalamic local field potential changes after DBS surgery in Parkinson's disease. Exp Neurol 2010;222:184-90.
59. Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012;11:140-9.
60. Frankemolle AMM, Wu J, Noecker AM, Voelcker-Rehage C, Ho JC, Vitek JL et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010;133(Pt 3):746-61.
61. Lee J-Y, Jeon BS, Paek SH, Lim YH, Kim M-R, Kim C. Reprogramming guided by the fused images of MRI and CT in subthalamic nucleus stimulation in Parkinson disease. Clin Neurol Neurosurg 2010;112:47-53.
62. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-86.
63. Brown P, Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin Neurophysiol 2005;116:2510-9. (Pubitemid 41543146)
64. Chen CC, Pogosyan A, Zrinzo LU, Tisch S, Limousin P, Ashkan K et al. Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol 2006;198:214-21. (Pubitemid 43243759)
65. Ince NF, Gupte A, Wichmann T, Ashe J, Henry T, Bebler M et al. Selection of optimal programming contacts based on local field potential recordings from subthalamic nucleus in patients with Parkinson's disease. Neurosurgery. 2010;67:390-7.
66. Abosch A, Lanctin D, Onarin I, Eberly L, Spaniol M, Ince NF. Long-term recordings of local field potentials from implanted deep brain stimulation electrodes. Neurosurgery 2012 [Epub ahead of print].